Login / Signup

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.

Sueli C S CarneiroPenelope Esther PalominosSônia Maria Alvarenga AntiRodrigo Luppino AssadRafaela Silva Guimarães GonçalvesAdriano ChiereghinAndre Marun LyrioAntônio Carlos XimenesCarla Gonçalves SaadCélio Roberto GonçalvesCharles Lubianca KohemCláudia Diniz Lopes MarquesCláudia Goldenstein SchainbergEduardo de Souza MeirellesGustavo Gomes ResendeLenise Brandao PieruccettiMauro Waldemar KeisermanMichel Alexandre YazbekPercival Degrava Sampaio-BarrosRicardo da Cruz LageRubens BonfiglioliThauana Luíza OliveiraValderílio Feijó AzevedoWashington Alves BianchiWanderley Marques BernardoRicardo Dos Santos SimõesMarcelo de Medeiros PinheiroCristiano Barbosa Campanholo
Published in: Advances in rheumatology (London, England) (2021)
Psoriatic arthritis (PsA) is a chronic and systemic immune disease characterized by inflammation of peripheral and/or axial joints and entheses in patients with psoriasis (PsO). Extra-articular and extracutaneous manifestations and numerous comorbidities can also be present. These recommendations replace the previous version published in May 2013. A systematic review of the literature retrieved 191 articles that were used to formulate 12 recommendations in response to 12 clinical questions, divided into 4 sections: diagnosis, non-pharmacological treatment, conventional drug therapy and biologic therapy. These guidelines provide evidence-based information on the clinical management for PsA patients. For each recommendation, the level of evidence (highest available), degree of strength (Oxford) and degree of expert agreement (interrater reliability) are reported.
Keyphrases